Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$2.05M Sell
42,406
-15,321
-27% -$691K 0.25% 46
2018
Q4
$2.37M Sell
57,727
-3,475
-6% -$143K 0.31% 39
2018
Q3
$2.51M Buy
61,202
+31
+0.1% +$1.25K 0.27% 50
2018
Q2
$2.43M Sell
61,171
-612
-1% -$23.5K 0.27% 46
2018
Q1
$2.31M Sell
61,783
-546
-0.9% -$22.1K 0.25% 50
2017
Q4
$2.66M Buy
62,329
+1,323
+2% +$52.8K 0.29% 45
2017
Q3
$2.24M Sell
61,006
-8,026
-12% -$324K 0.26% 45
2017
Q2
$3.13M Sell
69,032
-42,200
-38% -$1.86M 0.37% 27
2017
Q1
$4.73M Sell
111,232
-672
-0.6% -$27.4K 0.61% 26
2016
Q4
$4.49M Sell
111,904
-8,489
-7% -$328K 0.6% 25
2016
Q3
$4.67M Sell
120,393
-17,636
-13% -$666K 0.64% 29
2016
Q2
$4.78M Buy
138,029
+65,708
+91% +$2.28M 0.71% 33
2016
Q1
$2.5M Buy
+72,321
New +$2.52M 0.38% 83

Other funds holding HOLX

AT Bancorp's HOLX Position: Q1 2019 in Review

AT Bancorp reduced its Hologic (HOLX) stake by 27% in Q1 2019, selling an estimated $691K and leaving 42,406 shares worth $2.05M. The position accounts for 0.25% of the portfolio, ranked #46.

AT Bancorp first reported a position in HOLX in Q1 2016 and has held it in 13 quarters since. The position peaked at $4.78M in Q2 2016. 466 funds tracked by Wall St. Rank hold HOLX as of Q1 2019.

  • AT Bancorp held 42,406 shares of Hologic worth $2.05M as of Q1 2019.
  • AT Bancorp sold 15,321 Hologic shares in Q1 2019, an estimated $691K.
  • Hologic made up 0.25% of AT Bancorp's portfolio in Q1 2019, its #46 holding.
  • AT Bancorp first reported a position in Hologic in Q1 2016 and has held it in 13 quarters since.
  • AT Bancorp's Hologic position peaked at $4.78M in Q2 2016.
  • 466 funds tracked by Wall St. Rank held Hologic as of Q1 2019.

Based on AT Bancorp's 13F filing for Q1 2019, filed 13 May 2019.